Coherus BioSciences (FRA:8C5) Other Operating Expense : €0.0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2014. Start your Free Trial

What is Coherus BioSciences Other Operating Expense?

Coherus BioSciences's Other Operating Expense for the three months ended in Mar. 2025 was €0.0 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was €0.0 Mil.

Coherus BioSciences's quarterly Other Operating Expense declined from Sep. 2024 (€0.0 Mil) to Dec. 2024 (€0.0 Mil) and declined from Dec. 2024 (€0.0 Mil) to Mar. 2025 (€0.0 Mil).

Coherus BioSciences's annual Other Operating Expense declined from Dec. 2022 (€0.0 Mil) to Dec. 2023 (€-0.0 Mil) but then increased from Dec. 2023 (€-0.0 Mil) to Dec. 2024 (€0.0 Mil).

Coherus BioSciences Other Operating Expense Historical Data

The historical data trend for Coherus BioSciences's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coherus BioSciences Other Operating Expense Chart

Coherus BioSciences Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Operating Expense

Get a 7-Day Free Trial

Coherus BioSciences Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Operating Expense	Get a 7-Day Free Trial															-	-	-	-	-

Coherus BioSciences Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

Coherus BioSciences Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Coherus BioSciences's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Coherus BioSciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Coherus BioSciences Inc (FRA:8C5) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

CHRS:USA

Address

333 Twin Dolphin Drive, Suite 600, Redwood City, CA, USA, 94065

Website

https://www.coherus.com

Coherus BioSciences Inc is a commercial-stage biopharmaceutical company focused on the research, development and commercialization of innovative immunotherapies to treat cancer. Coherus is developing an innovative immuno-oncology pipeline which includes multiple antibody immunotherapy candidates focused on enhancing the innate and adaptive immune responses to enable a robust antitumor immunologic response and enhance outcomes for patients with cancer.

Coherus BioSciences Headlines

No Headlines